Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ona domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php on line 6131
Alzheimer's Drug Paves Way for a Potential Cure to Pregnancy Complications - Cord Blood

Cord Blood

and Stem Cell Banking

Alzheimer’s Drug Paves Way for a Potential Cure to Pregnancy Complications

Woman taking pill

The Unexpected Connection

Often, the answers we seek are right under our noses. That’s what Professors Surendra Sharma and Sukanta Jash from Brown University realized when they stumbled upon a potential cure for preeclampsia, a serious pregnancy complication. Intriguingly, this possible treatment was initially designed for Alzheimer’s disease.

What is Preeclampsia?

Preeclampsia is a condition that manifests during pregnancy, putting both mother and child at significant risk. Here’s a simple breakdown:

  • Blood Pressure Surge: Expecting mothers face spikes in blood pressure.
  • Symptoms Unfold: Along with high blood pressure, mothers can experience gastrointestinal tension.
  • Organ Threat: Vital organs, like kidneys and liver, may falter or stop working entirely.
  • Post-Pregnancy Risks: Some new mothers might encounter postpartum preeclampsia.
  • A Heartbreaking Statistic: Alarmingly, it’s a major reason many women lose their babies during pregnancy. This disorder is a substantial contributor to maternal and fetal mortality, leading to premature delivery, placental complications, and oxygen deprivation. Nearly 8% of global pregnancies grapple with this challenge.

A Remarkable Discovery

Here’s where Alzheimer’s and preeclampsia paths converge. Dr. Sharma and Dr. Jash zeroed in on an antibody developed for Alzheimer’s treatment. They noticed a common culprit: the cis P-tau protein. This protein was abundantly present in Alzheimer’s patients’ brains and, coincidentally, a significant marker for preeclampsia.

The connection was initially made by Drs. Kun Ping Lu and Xiao Zhen Zhou from Western Ontario University. Dr. Zhou, actively researching Alzheimer’s, was examining a drug aimed at this very protein in the brain.

Sensing an opportunity, Drs. Sharma and Jash decided to see if the same Alzheimer’s drug might combat preeclampsia. After receiving the necessary permissions, they conducted tests on mice with this condition. Their findings were beyond encouraging. Dr. Sharma shared, “In our study, we found the cis P-tau antibody efficiently counteracted the harmful protein in the blood and placenta. It rectified all preeclampsia-associated symptoms in mice.”

A Glimmer of Optimism

Post-treatment, the mice exhibited marked improvements. Their high blood pressure normalized, excess protein in urine diminished, and fetal growth returned to regular patterns. In essence, they experienced a typical pregnancy.

Recalling their shared past, Lu mentioned having met Sharma in 2019 during a lecture at Brown University. Reflecting on their collaborative journey, he remarked, “Science is full of surprises. I hadn’t envisioned working on preeclampsia treatment. This just proves how transformative collaborations can be.”

The Road Ahead

Emboldened by their findings, Dr. Sharma and his team are now on a mission. Their goals:

  • Early Detection: Develop a system for detecting preeclampsia in its early stages. Currently, diagnosis usually occurs around the 20-week mark. Earlier detection could revolutionize treatment.
  • Broadening Treatment Avenues: The team aims to innovate more treatment methods to diminish the condition’s repercussions.

Dr. Sharma is optimistic. He believes that leveraging the Alzheimer’s drug as a potential treatment marks significant progress in the fight against preeclampsia.